OTCMKTS:PSID - PositiveID Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.0087 0.00 (-2.25 %)
(As of 07/16/2018 04:00 PM ET)
Previous Close$0.0089
Today's Range$0.0076 - $0.0130
52-Week Range$0.0054 - $46.80
Volume10.74 million shs
Average Volume641,483 shs
Market Capitalization$80,000.00
P/E RatioN/A
Dividend YieldN/A
PositiveID Corporation, together with its subsidiaries, develops and sells molecular diagnostic systems for bio-threat detection and rapid medical testing. The company focuses on microfluidic systems for the automated preparation and performance of biological assays to detect biological threats at high-value locations and analyze biological samples at the point of need. It has a portfolio of intellectual property related to sample preparation and rapid medical testing applications. The company's M-BAND technology is a bio-aerosol monitor with integrated systems for sample collection, processing, and detection modules. Its M-BAND technology analyzes air samples for the detection of pathogenic bacteria, viruses, and toxins for up to 30 days. The company's Firefly Dx is an automated pathogen detection system for rapid diagnostics for clinical and point-of-need applications. Its Firefly Dx system detects and identifies common pathogens and diseases, such as E. coli, methicillin-resistant staphylococcus aureus, methicillin-susceptible staphylococcus aureus, clostridium difficile, influenza, and others. In addition, PositiveID Corporation markets the Caregiver, a non-contact clinical thermometer that measures forehead temperature in adults, children, and infants for hospitals, physicians' offices, medical clinics, nursing homes and other long-term care institutions, and acute care hospitals; and manufactures and sells specialty technology vehicles for mobile laboratory and communications applications. The company was formerly known as VeriChip Corporation and changed its name to PositiveID Corporation in November 2009. PositiveID Corporation was founded in 2001 and is headquartered in Delray Beach, Florida.

Receive PSID News and Ratings via Email

Sign-up to receive the latest news and ratings for PSID and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Analytical instruments


Debt-to-Equity RatioN/A
Current Ratio0.01
Quick Ratio0.01


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.36 million
Price / Sales0.02
Cash FlowN/A
Price / CashN/A
Book Value($27.01) per share
Price / Book0.00


EPS (Most Recent Fiscal Year)N/A
Net Income$-8,560,000.00
Net Margins-166.73%
Return on EquityN/A
Return on Assets-304.11%


Outstanding Shares9,390,000
Market Cap$0.08

The Truth About Cryptocurrencies

PositiveID (OTCMKTS:PSID) Frequently Asked Questions

What is PositiveID's stock symbol?

PositiveID trades on the OTCMKTS under the ticker symbol "PSID."

How were PositiveID's earnings last quarter?

PositiveID Corp (OTCMKTS:PSID) issued its quarterly earnings data on Friday, May, 18th. The company reported ($0.95) EPS for the quarter. The company had revenue of $0.42 million for the quarter. View PositiveID's Earnings History.

When is PositiveID's next earnings date?

PositiveID is scheduled to release their next quarterly earnings announcement on Tuesday, August, 21st 2018. View Earnings Estimates for PositiveID.

What is the consensus analysts' recommendation for PositiveID?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PositiveID in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are some of PositiveID's key competitors?

Who are PositiveID's key executives?

PositiveID's management team includes the folowing people:
  • Mr. William J. Caragol, Chairman, CEO & Acting CFO (Age 51)
  • Mr. Lyle L. Probst, Pres (Age 47)
  • Dr. Kimothy Smith, Chief Technology Advisor & Member of Advisory Board
  • Mr. Gary J. O'Hara, Chief Technology Officer (Age 68)
  • Ms. Allison F. Tomek, Sr. VP of Corp. Devel. & Sec.

Has PositiveID been receiving favorable news coverage?

Headlines about PSID stock have been trending somewhat negative recently, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. PositiveID earned a coverage optimism score of 0.00 on Accern's scale. They also assigned media coverage about the company an impact score of 44.27 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of PositiveID?

Shares of PSID can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PositiveID's stock price today?

One share of PSID stock can currently be purchased for approximately $0.0087.

How big of a company is PositiveID?

PositiveID has a market capitalization of $80,000.00 and generates $5.36 million in revenue each year. PositiveID employs 9 workers across the globe.

How can I contact PositiveID?

PositiveID's mailing address is 1690 SOUTH CONGRESS AVENUE SUITE 201, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-805-8008.

MarketBeat Community Rating for PositiveID (OTCMKTS PSID)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  57 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  114
MarketBeat's community ratings are surveys of what our community members think about PositiveID and other stocks. Vote "Outperform" if you believe PSID will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PSID will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.